Development and tolerization of hyperacute rejection in a transgenic mouse graft versus host model

Transplantation

Volumn 94, Issue 3, 2012, Pages 234-240

  Oh, Soyoung ^a   Schwartz, Ronald H ^b   Singh, Nevil J ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

B cell tolerance; Cellular therapy; Hyperacute rejection; T cell activation; Tolerance

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HELPER CELL; HYPERACUTE GRAFT REJECTION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; TRANSPLANTATION TOLERANCE;

ALLELES; ANIMALS; B-LYMPHOCYTES; CELL SEPARATION; COHORT STUDIES; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST REACTION; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; T-LYMPHOCYTES;

EID: 84864659330     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31825ccb91     Document Type: Article

References (23)

1. Williams GM, Hume DM, Hudson RP Jr, et al. "Hyperacute" renalhomograft rejection in man. N Engl J Med 1968; 279: 611.
2. Platt JL. The immunological barriers to xenotransplantation. Crit Rev Immunol 1996; 16: 331.
3. Thomas F, Naff G, Thomas J, et al. Prevention of hyperacute kidney rejection of decomplementation using purified cobra venom factor. J Surg Res 1977; 22: 189.
4. Yoshioka H, McCalmon RT Jr, Putnam CW, et al. Attenuation of hyperacute xenograft rejection in unmodified host by extracorporeal plasma perfusion. Transplantation 1977; 24: 78.
5. Terman DS, Garcia-Rinaldi R, McCalmon R, et al. Modification of hyperacute renal xenograft rejection after extracorporeal immunoadsorption of heterospecific antibody. Int J Artif Organs 1979; 2: 35.
6. Hammer C, Krebs G, Chaussy C, et al. Mitigation of hyperacute rejection by antilymphocyte globulin (ALG). Transplant Proc 1979; 11: 31.
7. Pruitt SK, Baldwin WM III, Marsh HC Jr, et al. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 1991; 52: 868.
8. Gaber LW, Gaber AO, Vera SR, et al. Successful reversal of hyperacute renal allograft rejection with the anti-CD3 monoclonal OKT3. Transplantation 1992; 54: 930.
9. Dalmasso AP, Platt JL. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor. Transplantation 1993; 56: 1171.
10. Pruitt SK, Baldwin WM III, Barth RN, et al. The effect of xenoreactive antibody and B cell depletion on hyperacute rejection of guinea pig-torat cardiac xenografts. Transplantation 1993; 56: 1318.
11. Tearle RG, Tange MJ, Zannettino ZL, et al. The alpha-1,3- galactosyltransferase knockout mouse. Implications for xenotransplantation. Transplantation 1996; 61: 13.
12. Bach FH, Robson SC, Winkler H, et al. Barriers to xenotransplantation. Nat Med 1995; 1: 869.
13. Kuwaki K. Heart transplantation in baboons using alpha1,3- galactosyltransferase gene-knockout pigs as donors: initial experience. 2005; 11: 29.
14. Miller C, Ragheb JA, Schwartz RH. Anergy and cytokine-mediated suppression as distinct superantigen-induced tolerance mechanisms in vivo. J Exp Med 1999; 190: 53.
15. Singh NJ, Chen C, Schwartz RH. The impact of T cell intrinsic antigen adaptation on peripheral immune tolerance. PLoS Biol 2006; 4: e340.
16. Padgett KA, Shreffler DC, Saha BK. Molecular mapping of murine I region recombinants. III. Crossing over at two discrete sites within the beta 1Ybeta 2 intron of the E beta gene. J Immunol 1991; 147: 2764.
17. Tanchot C, Barber DL, Chiodetti L, et al. Adaptive tolerance of CD4+ T cells in vivo: multiple thresholds in response to a constant level of antigen presentation. J Immunol 2001; 167: 2030.
18. Platt JL. A perspective on xenograft rejection and accommodation. Immunol Rev 1994; 141: 127.
19. Xu H, Exner BG, Chilton PM, et al. CD45 congenic bone marrow transplantation: evidence for T cell-mediated immunity. Stem Cells 2004; 22: 1039.
20. Herndon JM, Stuart PM, Ferguson TA. Peripheral deletion of antigenspecific T cells leads to long-term tolerance mediated by CD8+ cytotoxic cells. J Immunol 2005; 174: 4098.
21. Sharabi Y, Aksentijevich I, Sundt TM III, et al. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990; 172: 195.
22. Yang YG, deGoma E, Ohdan H, et al. Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med 1998; 187: 1335.
23. Lassila O, Vainio O, Matzinger P. Can B cells turn on virgin T cells? Nature 1988; 334: 253.